Skip to main
University-wide Navigation

Markey Announces First Cohort of High School Students for ACTION Program

After reviewing more than 90 applications for the program, a Markey committee has selected 20 high school students to enroll in the ACTION program for the 2019 class.

New NanoString nCounter SPRINT Profiler Available

The Genomics Core Laboratory and the MCC Oncogenomics Shared Resource Facility have a new NanoString nCounter SPRINT Profiler available for use.

Markey Hosting OncLive Summit on Neuroendocrine Tumors

The University of Kentucky Markey Cancer Center is hosting OncLive’s State of the Science Summit with a focus on neuroendocrine tumors on Saturday, April 20, 2019.

ACA Medicaid Expansion Increases Colon Cancer Screenings, Survival in Ky

A University of Kentucky study published in the Journal of the American College of Surgeons shows a direct link between the adoption of the Affordable Care Act (ACA) Medicaid expansion and the impact of colon cancer on Kentuckians.

Clinical Trial Gives UK Pathologist New Hope

As a pathologist at the University of Kentucky, Dr. Charles Lutz helps patients behind the scenes, matching patients who need both solid organ and bone marrow transplants with appropriate donors. But when he was diagnosed with an aggressive prostate cancer in 2011, Lutz found himself on the other side of the table.

UK Study Shows Promise Toward Prevention of Melanoma

In a study published in the Journal of Biological Chemistry, a team of University of Kentucky researchers have discovered specific protein interactions that may help cells resist ultraviolet (UV) damage and carcinogenesis.

Daret St. Clair Receives Lifetime Achievement Award from International Society

University of Kentucky Markey Cancer Center researcher Daret St. Clair, Ph.D., has been named the 2018 Lifetime Achievement Award Recipient from the Society for Redox Biology and Medicine (SfRBM).

New NCI Grant Expands Markey’s Successful Oncology Training Program to High Schoolers

After successfully launching an oncology training program for Appalachian undergrads in 2016, the University of Kentucky Markey Cancer Center is expanding the program to include high school students.

UK Study Finds Promising Therapeutic Target for Aggressive Type of Breast Cancer

A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer.

A Promise We Intend to Keep

Kentucky faces the highest cancer incidence and mortality rates in the United States. Researchers at the University of Kentucky aim to reduce these numbers by half. We believe that’s what Kentucky can do.